ArticlePloS one2013

Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes.

Tomader Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.